Viewing Study NCT05751018


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-03-06 @ 7:41 PM
Study NCT ID: NCT05751018
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2023-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
Sponsor:
Organization: